Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Dexter

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|November 21, 1987
Increased nigral iron content in postmortem parkinsonian brainD T Dexter, F R Wells, F Agid, et al.
Neuroreport|September 8, 1994
Nigral dopaminergic cell loss in vitamin E deficient ratsD T Dexter, I Nanayakkara, M A Goss-Sampson, et al.
Annals of Neurology|September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJ Sian, D T Dexter, A J Lees, et al.
Neuroscience|January 22, 2003
Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and femalesH E Murray, A V Pillai, S R McArthur, et al.
Neuropathology and Applied Neurobiology|April 28, 2006
Comparative study of commercially available anti-alpha-synuclein antibodiesE Croisier, D Elfant MRes, M Deprez, et al.
Journal of Neurochemistry|February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's diseaseD T Dexter, C J Carter, F R Wells, et al.
Neurogenetics|May 16, 2006
Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's diseaseD C Duke, L B Moran, M E Kalaitzakis, et al.
Journal of the Neurological Sciences|July 17, 1998
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseasesM Gu, A D Owen, S E Toffa, et al.
The Journal of Pharmacy and Pharmacology|May 15, 2004
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's diseaseK P Datla, R D Bennett, V Zbarsky, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|November 21, 1987
Increased nigral iron content in postmortem parkinsonian brainD T Dexter, F R Wells, F Agid, et al.
Neuroreport|September 8, 1994
Nigral dopaminergic cell loss in vitamin E deficient ratsD T Dexter, I Nanayakkara, M A Goss-Sampson, et al.
Annals of Neurology|September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaJ Sian, D T Dexter, A J Lees, et al.
Neuroscience|January 22, 2003
Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and femalesH E Murray, A V Pillai, S R McArthur, et al.
Neuropathology and Applied Neurobiology|April 28, 2006
Comparative study of commercially available anti-alpha-synuclein antibodiesE Croisier, D Elfant MRes, M Deprez, et al.
Journal of Neurochemistry|February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's diseaseD T Dexter, C J Carter, F R Wells, et al.
Neurogenetics|May 16, 2006
Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's diseaseD C Duke, L B Moran, M E Kalaitzakis, et al.
Journal of the Neurological Sciences|July 17, 1998
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseasesM Gu, A D Owen, S E Toffa, et al.
The Journal of Pharmacy and Pharmacology|May 15, 2004
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's diseaseK P Datla, R D Bennett, V Zbarsky, et al.
Annals of Neurology|October 1, 1992
Alpha-tocopherol levels in brain are not altered in Parkinson's diseaseD T Dexter, R J Ward, F R Wells, et al.
Pageof 4